Permanent Pacemaker Predictors with SAPIEN 3

Permanent Pacemaker Predictors with SAPIEN 3The aim of this study was to identify permanent pacemaker (PPM) predictors after transcatheter aortic valve replacement (TAVR) with last generation balloon expandable valve Edwards SAPIEN 3.

 

The new conduction disturbances requiring PPM are one of the biggest concerns after TAVR, and their predictors have not yet been defined.

 

229 patients undergoing TAVR with balloon expandable SAPIEN 3 were analyzed looking into:

  • influence of angiographic implantation depth
  • device landing zone calcium volume
  • oversizing
  • pre and post dilation
  • baseline conduction disturbances

 

In all, 14.4% of patients required PPM implantation.

 

Those requiring PPM presented higher left ventricular outflow tract (LVOT) in the area below the left coronary cusp (23.7 mm3 vs. 3.0 mm3; p<0.001) and under the right coronary cusp (6.6 mm3 vs. 0.3 mm3; p=0.014).

 

There was also higher prevalence of right bundle branch block in patients receiving PPM (15% vs. 2%, p=0.004) and lower implantation depth (ventricular portion 29 ± 12% vs. 21 ± 5%; p<0.001).

 

After multivariable analysis PPM predictors were:

  • LVOT calcium volume in the area below the left coronary cusp higher than 13.7 mm3
  • LVOT calcium volume in the area below the right coronary cusp higher than 4.8 mm3
  • Baseline bundle branch block
  •  25.5% or higher ventricular portion, as regards implantation depth.

 

When modifying implantation technique aiming at higher valve implantation, implantation depth decreased from 24% to 21% (p = 0.012) ventricular portion, accompanied by a decrease in PPM rate (19.2% vs. 9.2%; p=0.038).

 

Conclusion

Left ventricular outflow track below the left and right coronary cusps, right bundle branch block and implantation depth are independent predictors of PPR need after TAVR. Patients can be stratified using all four variables. Slightly higher implantation could reduce PPM rate.

 

Editorial Comment

This analysis addresses the fact that PPM need is not as innocuous as we used to think. Initially, a systematic review and meta-analysis carried out by Dr. Ander Regueiro and published in Circ Cardiovasc Interv had concluded that PPM need does not increase mortality rate.

 

However, later studies by Dr. Opeyemi and Dr. Gennaro Giustino, published in J Am Coll Cardiol Intv and EuroIntervention respectively, showed PPM need was associated to events such as death.

 

Recent studies comparing the SAPIEN XT with the SAPIEN 3 have suggested the last generation valves (SAPIEN 3) show less paravalvular leak but more PPM need (Fernando De Torres-Alba et al. J Am CollCardiolIntv).

 

We should bear in mind all the above mentioned studies were published in 2016, which means there is nothing permanent about PPM need after TAVR.

 

Original Title: Predictors of Permanent Pacemaker Implantation after Transcatheter Aortic Valve Replacement with the SAPIEN 3.

Reference: Victor Mauri et al. J Am Coll Cardiol Intv. 2016;9(21):2200-2209.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...

J-Valve for Chronic AR: 30-Day Outcomes of Transfemoral Valve J-Valve in Chronic Aortic Regurgitation

Chronic aortic regurgitation (AR) poses a significant challenge as far as transcatheter alternatives go due to the absence of calcification and a suitable anchoring...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...